REG-Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 98,648 of its own ordinary shares between July 13 and July 17, 2026, as part of the buyback program announced on June 9. The shares were acquired at an average price of €26.00 per share, for a total cost of approximately €2.56 million.
Key figures
- Shares held
- 511049
- Avg price eur
- 26
- Total cost eur
- 2564633.73
- Shares repurchased
- 98648
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.